Regentis Biomaterials RGNT
NYSE RGNT
$1.51 +0.04 (+2.72%)
As of: Oct 21, 2026 · 1:51 PM EDT

Regentis Biomaterials (RGNT) Notes Payables (2024 - 2025)

Updated

Regentis Biomaterials' Notes Payables was $1.2 million in Q4 2025, up 108.9% from $573,000 a year earlier.

Analysis

Regentis Biomaterials (RGNT) Notes Payables (2024 - 2025) Analysis & Trends

  • In earlier years, Notes Payables was $573,000 in FY2024 (+172.9%) and $210,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.26 Bn 237.29 Bn 4.88 Bn
2 Abbott Laboratories 172.13 Bn 142.56 Bn 7.27 Bn
3 Danaher 163.58 Bn 147.39 Bn 3.61 Bn
4 Intuitive Surgical 151.88 Bn 131.31 Bn 1.96 Bn
5 Medtronic 119.19 Bn 84.44 Bn 6.34 Bn
6 Stryker 113.63 Bn 99.75 Bn 4.50 Bn
7 Boston Scientific 65.06 Bn 59.83 Bn 3.85 Bn
8 Becton Dickinson 53.41 Bn 50.56 Bn 2.32 Bn
9 Edwards Lifesciences 50.75 Bn 34.76 Bn 1.35 Bn
10 Regentis Biomaterials 855,783.43 855,783.43 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.20 Mn
Dec 31, 2024 573,000.00
API Access

Regentis Biomaterials Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=RGNT&period=max&api_key=YOUR_API_KEY